| Patent application number | Description | Published |
|---|
| 20080293680 | Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II - The invention relates to a compound of the formula (I), wherein R | 11-27-2008 |
| 20090042867 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to substituted 1,2-ethylenediamines of general formula (I), | 02-12-2009 |
| 20090099159 | Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds - A method of treating or preventing of a disease or condition associated with an increased level of isoforms of amyloid β peptides (Aβ) and/or with a changed ratio of levels of Aβ isoforms and/or with the formation of plaques containing amyloid β peptide (Aβ) isoforms in a mammal comprising administering to said mammal an therapeutically effective amount of a compound selected from the formulas Ia, Ib | 04-16-2009 |
| 20090325940 | Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof - The present invention relates to substituted 1,2-ethylenediamines of general formula (I) | 12-31-2009 |
| 20100144681 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to substituted 1,2-ethylenediamines of general formula (I), | 06-10-2010 |
| 20100168070 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to substituted 1,2-ethylenediamines of general formula (I), | 07-01-2010 |
| 20100204160 | SUBSTITUTED 1,2-ETHYLENEDIAMINES, METHODS FOR PREPARING THEM AND USES THEREOF - The present invention relates to substituted 1,2-ethylenediamines of general formula (I) | 08-12-2010 |
| 20100298278 | INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention relates to the substituted 1,2-ethylenediamines of general formula (I), | 11-25-2010 |
